Limitations, agreements, and source contact

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma · Source last updated 2023-07-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

limitations And Caveats

description

All these analyses will be descriptive and exploratory and hypotheses generating in nature.

point Of Contact

email

rleong@chla.usc.edu

organization

Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)

phone

323-361-5132

title

Roy Leong

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice